Загрузка...
Molecular sampling of prostate cancer: a dilemma for predicting disease progression
BACKGROUND: Current prostate cancer prognostic models are based on pre-treatment prostate specific antigen (PSA) levels, biopsy Gleason score, and clinical staging but in practice are inadequate to accurately predict disease progression. Hence, we sought to develop a molecular panel for prostate can...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2855514/ https://ncbi.nlm.nih.gov/pubmed/20233430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-8794-3-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|